ASDR
2020 ASDR Virtual Meeting
Australasian Society for Dermatology Research
20-21 November 2020
ASDR
The objectives and aims of the Association are
-
To promote scientific research in dermatology, skin biology and allied subjects through the study of individual humans, animals and model systems.
-
To provide a forum for interaction and information exchange between doctors treating patients with disorders of the skin and scientists working in the field of cutaneous research.
​
-
To enhance the treatment of people with disorders of the skin through making available the latest advances in research and diagnostic techniques.
​
-
To investigate possible sources of funding for skin research.
​
-
To establish links with the International Skin Research Societies, in particular the American Society of Investigative Dermatology, the Japanese Society of Investigative Dermatology, the British Society of Investigative Dermatology and the European Society of Dermatology Research. In addition to establishing formal links with these societies, The Australasian Society of Dermatology Research would aim to participate in joint meetings.
Program
Australian Eastern Standard Time (AEST)
Note that Daylight saving is not observed in QLD!!!
09:30-09:35
Opening by Prof Dedee Murrell (2020 ASDR president)
09:35-10:30
Session 1 - sponsored by Janssen chaired by Prof Dedee Murrell
09:35-09:50
Daniel Furtner (Janssen)
Janssen’s Pipeline: Addressing Unmet Needs in Immunodermatology
09:50-10:10
Prof Emma Guttman
Translational Research in Atopic Dermatitis and Novel Treatments
10:10-10:20
Yicong Liang
Evaluation of the Toxicity of Glucocorticoids in Patients with Autoimmune Blistering Disease (AIBDs) Using the Glucocorticoid Toxicity Index (GTI)
10:20-10:30
Kate Simpson
A comparison of the EUROIMMUN Dermatology Profile ELISA compared to the novel BIOCHIP Mosaic 7 in the diagnosis of immunobullous disease in the Australian population
10:30-10:45
Morning break
10:45-12:10
Session 2 - chaired by Prof Peter Soyer
10:45-11:15
A/Prof Michael Samuel
Enhancing mechano-reciprocity: a new approach to accelerating the healing of diabetic wounds
11:15-11:30
Dr Mitchell Stark
Mutational profiling in benign neoplasms of the skin
11:30-11:45
Dr Loredana Spoerri
Melanoma phenotypic heterogeneity is regulated by MITF-mediated cell matrix interaction
11:45-12:00
Prof Tarl Prow
Next generation technologies for quantifying skin ageing
12:00-12:10
Ho Yi Wong
Targeting field cancerisation in epidermal cancers
12:10-13:10
Lunch break
13:10-13:55
Session 3 - chaired by Dr Mitchell Stark
13:10-13:25
Dr Oliver Dreesen
Identification and Quantification of Senescent Cells In UV-induced Skin Pathologies
13:25-13:35
Racheal Wadlow
Investigating the Contribution of Vascular Sox9 to Fibrosis in Scleroderma
13:35-13.45
Dr Farzana Ahmed
Distinct molecular signatures orchestrate tumor subpopulations in melanoma models mimicking tumor microenvironment and drug tolerance
13:45-13:55
Ghazaleh Hashemi Mazlaghanian
The Effect of Conditional Sox9 Knockout in the Endothelium on Melanoma Tumour Vascularisation and Metastasis
15:30
AGM
09:30-11:00
Session 4 - chaired by A/Prof Joe Rothnagel
09:30-09:45
Dr Zlatko Kopecki
Multifunctional Ultrasmall AgNP Hydrogel Accelerates Healing of S. aureus Infected Wounds
09:45-10:00
Prof Kiarash Khosrotehrani
Cell fate decisions in endothelial cells determine skin wound scarring
10:00-10:15
Prof Allison Cowin
Development of cell-based therapies for wound repair
10:15-10:30
Dr Christina Bursill
High-density lipoproteins rescue diabetes-impaired wound healing
10:30-11:00
Prof Carlos Clavel
Regulation of the Hair Follicle Stem Cell Niche Fate during growth, pigmentation and ageing
11:00 -11:25
Morning break
11:25-12:45
Session 5 - chaired by Prof Nikolas Haass
11:25-11:35
Ruby Lee
Evolution of skin cancers in organ transplant recipients at a high-throughput surveillance clinic in Queensland
11:35-11:45
Dr John Frew
Molecular Insights into the Pathogenesis of Hidradenitis Suppurativa using a Translational Medicine Approach: From Bedside to Bench and Back Again
11:45-12:15
Prof Katsuto Tamai
Drug development for regenerating epidermal stem cells in epidermolysis bullosa patients
12:15-12:30
A/Prof Johannes Kern
First insights into EB related pain from a DDEB mouse model
12:30-12:45
Prof Dedee Murrell
The importance of developing validated outcome measures for clinical trials in dermatology
12:45-13:30
Lunch break
13:30-14:40
Regsitrars forum - chaired by Prof Helmut Schaider
13:30-14:00
Dr Ajit Viswalingam (Novartis)
Novartis’ Immunodermatology Pipeline - In for the long run
14:00-14:10
Janice Yeon
Dermatological presentations for a walk-in skin clinic in Fiji
14:10-14:20
Nick De Rosa
Skin disease in Australian heart and lung transplant recipients
14:20-14:30
Thomas Stewart
Cellular Neurothekeoma
14:30-14:40
Andrew Swarbrick
Cutaneous Malakoplakia: A failure to phagocytose
14:40-14:50
Afternoon break
14:50-15:00
Awards & closing remarks by Prof Kiarash Khosrotehrani (2021 ASDR president)
Abstracts
Abstract submission deadline: Tuesday 3 November
Extended to Sunday 8 November!
Submit an abstract of max 300 words to ASDR2020virtual@gmail.com and indicate whether you wish to apply for a "poster", "oral" or "poster & oral" presentation. Please also indicate if you wish to present during any of the two registrars forums.
Awards
Kindly offered by
4 x $250 awards for the 4 best abstract presentations!
Contacts
General inquiries to
ASDR 2020 virtual meeting is supported by
Sponsors
